gland type
Recently Published Documents


TOTAL DOCUMENTS

230
(FIVE YEARS 64)

H-INDEX

24
(FIVE YEARS 3)

Medicine ◽  
2022 ◽  
Vol 101 (2) ◽  
pp. e28469
Author(s):  
Huan Zhang ◽  
Shuyan Wang ◽  
Yongping Zhang ◽  
Fusang Ye ◽  
Chunnian Wang

Author(s):  
Thottukadavil S. Priya ◽  
Chakramakal Joseph Andrews ◽  
S. Suresh Kumar ◽  
S. Divya

<p class="abstract">Sinonasal teratocarcinosarcoma (TCS) is a very rare malignant neoplasm of sinonasal tract with intermixed teratomatous, carcinomatous and sarcomatous elements. While the diagnosis is largely based on tissue analysis and immunohistochemistry, the mode of management demands further study. Surgical resection with or without chemotherapy and radiation therapy is currently the most accepted treatment regimen. Locally aggressive, while also associated with metastatic lesions, SNTCS is not easily resectable owing to its location and possible intracranial extension. Due to its aggressive nature over one-third of TCS tend to recur leading to treatment failure with a mean survival time of 1.9 years. Possible differentials include squamous cell carcinoma, olfactory neuroblastoma, adenocarcinoma, malignant mixed tumor of salivary gland type, undifferentiated carcinoma, malignant craniopharyngioma, mucoepidermoid carcinoma, transitional carcinoma of Schneiderian type and adenosquamous carcinoma. In this report, we present a case of TCS in a 55 years old male patient who presented to us with complaints of hyposmia, blurring of vision, diplopia and epiphora.</p>


2021 ◽  
Vol 22 ◽  
Author(s):  
Akinari Kakumoto ◽  
Hajime Kuroda ◽  
Tsengelmaa Jamiyan ◽  
Takeshi Shimakawa ◽  
Atsuko Masunaga

2021 ◽  
Vol 145 (11) ◽  
pp. 1379-1386
Author(s):  
Minhua Wang ◽  
Syed Gilani ◽  
Haodong Xu ◽  
Guoping Cai

Context.— Salivary gland-type tumors (SGTs) of the lung represent a distinct group of lung neoplasms. Pulmonary SGTs often pose diagnostic challenges, especially in small biopsy and cytology samples because of limited sample volume and overlapping morphology among pulmonary SGTs, metastatic SGTs of head and neck origin, and other lung tumors. Objective.— To identify the clinical characteristics, histomorphology, immunophenotypic features, and molecular alterations that are crucial for the diagnosis and differential diagnosis of pulmonary SGTs, especially in small biopsy and cytology specimens. Data Sources.— Literature review and authors' personal practice experience. Conclusions.— An accurate diagnosis of pulmonary SGTs can be achieved by careful evaluation of clinical findings and histomorphology in conjunction with immunohistochemical studies and molecular analysis.


2021 ◽  
Vol 156 (Supplement_1) ◽  
pp. S150-S150
Author(s):  
P Q Deb ◽  
D Suster

Abstract Introduction/Objective Primary pulmonary salivary gland-type carcinomas are rare malignancies that arise from minor salivary gland tissue present within seromucinous submucosal glands within the lower respiratory tract. Due to their rarity (~ &lt;1% of all primary lung malignancies), the epidemiological features and outcome of these malignancies are not well documented. Data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database was analyzed to identify cases of primary pulmonary salivary gland carcinoma. The most common tumor types included mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (ADCC), and epithelial-myoepithelial carcinoma (EMEC). The tumors were analyzed for overall survival across various epidemiological factors. Methods/Case Report All patients diagnosed with MEC, ADCC, and EMEC with the lung designated as the primary site between the period of 1975 to 2017 were analyzed. We calculated overall survival and disease-specific survival with Kaplan-Meier curves and Cox proportional hazards models using SPSS v25. Results (if a Case Study enter NA) 323 cases of MEC, 284 cases of ADCC, and 6 cases of EMEC diagnosed as primary lung carcinoma were identified. Age distribution analysis of the patients showed a unimodal distribution for both MEC and ADCC with most patients being diagnosed after the age of 40. 54% of MEC patients were male, while 48% of ADCC patients were male. The majority of patients were Caucasians (77% for MEC and 83% for ADCC patients). Both disease-specific and overall survival were worse for patients diagnosed at the age of 60 years or above. Race or sex did not significantly affect patients’ survival. High-grade MEC showed significantly worse prognosis than low or intermediate grade MEC. EMEC cases were too few (n=6) to perform reliable survival analysis, however, the age of diagnosis was higher (45 and above) with a higher incidence among black population (50%). Conclusion Comprehensive review of clinical and epidemiological features of primary salivary gland-type lung carcinoma show that the age of diagnosis and tumor grade are the most significant factor in determining the survival of these patients.


Endoscopy ◽  
2021 ◽  
Author(s):  
Tsutomu Takeda ◽  
Hiroya Ueyama ◽  
Kuang-I Fu ◽  
Satoshi Murata ◽  
Akihito Nagahara

Sign in / Sign up

Export Citation Format

Share Document